Cardiac toxicity of combined vemurafenib and cobimetinib administration
.

Author: EleftheriouGeorgios, FiocchiRoberto, GalloMariapina, GoriMauro, TaddeiFilippo, TrevisaniLaura

Paper Details 
Original Abstract of the Article :
Vemurafenib and cobimetinib are extremely effective in treating V600E-mutated metastatic melanoma, but their use is associated with toxic cardiac effects. Vemurafenib-induced prolonged QTc interval may be associated with ventricular fibrillation and sudden cardiac death. Cobimetinib-induced myocardi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.5414/CP203379

データ提供:米国国立医学図書館(NLM)

Cardiac Toxicity of Vemurafenib and Cobimetinib: A Desert Sandstorm on the Heart

Vemurafenib and cobimetinib, powerful drugs used to treat melanoma, can have significant side effects on the heart. This case report explores the cardiac toxicity of these drugs, highlighting the potential for serious complications. It's like navigating a desert landscape, where a sudden sandstorm can disrupt the delicate balance of the ecosystem.

The case report describes a patient who developed severe cardiac complications after receiving vemurafenib and cobimetinib, including prolonged QTc interval, reduced heart function, and ventricular fibrillation. This highlights the importance of careful monitoring and managing these side effects.

Navigating the Risks

This case report emphasizes the potential cardiac toxicity of vemurafenib and cobimetinib. It's like understanding the dangers of a desert sandstorm, knowing how to prepare and navigate through its destructive force.

Protecting Your Heart

This research highlights the importance of careful monitoring and managing potential side effects of medication. It's like watching for signs of a desert sandstorm, knowing when to take shelter and protect yourself.

Dr.Camel's Conclusion

This case report underscores the importance of careful consideration when treating cancer with vemurafenib and cobimetinib. It's like navigating a treacherous desert, knowing the risks and taking precautions to ensure a safe journey.

Date :
  1. Date Completed 2019-08-05
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

30704555

DOI: Digital Object Identifier

10.5414/CP203379

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.